Prosight Management, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $337 Million distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Galapagos Nv with a value of $28.2M, Acadia Healthcare Company, Inc. with a value of $27.4M, Bridge Bio Pharma, Inc. with a value of $27.3M, Meira G Tx Holdings PLC with a value of $26.7M, and Ab Cellera Biologics Inc. with a value of $21.5M.

Examining the 13F form we can see an decrease of $35.7M in the current position value, from $372M to 337M.

Prosight Management, LP is based out at Dallas, TX

Below you can find more details about Prosight Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $337 Million
Healthcare: $337 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $337 Million
  • Prior Value $372 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 7 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 15 stocks
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.